<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34118929</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1742-2094</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of neuroinflammation</Title><ISOAbbreviation>J Neuroinflammation</ISOAbbreviation></Journal><ArticleTitle>Targeting S100A4 with niclosamide attenuates inflammatory and profibrotic pathways in models of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>132</StartPage><MedlinePgn>132</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">132</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12974-021-02184-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">An increasing number of studies evidences that amyotrophic lateral sclerosis (ALS) is characterized by extensive alterations in different cell types and in different regions besides the CNS. We previously reported the upregulation in ALS models of a gene called fibroblast-specific protein-1 or S100A4, recognized as a pro-inflammatory and profibrotic factor. Since inflammation and fibrosis are often mutual-sustaining events that contribute to establish a hostile environment for organ functions, the comprehension of the elements responsible for these interconnected pathways is crucial to disclose novel aspects involved in ALS pathology.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Here, we employed fibroblasts derived from ALS patients harboring the C9orf72 hexanucleotide repeat expansion and ALS patients with no mutations in known ALS-associated genes and we downregulated S100A4 using siRNA or the S100A4 transcriptional inhibitor niclosamide. Mice overexpressing human FUS were adopted to assess the effects of niclosamide in vivo on ALS pathology.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We demonstrated that S100A4 underlies impaired autophagy and a profibrotic phenotype, which characterize ALS fibroblasts. Indeed, its inhibition reduces inflammatory, autophagic, and profibrotic pathways in ALS fibroblasts, and interferes with different markers known as pathogenic in the disease, such as mTOR, SQSTM1/p62, STAT3, &#x3b1;-SMA, and NF-&#x3ba;B. Importantly, niclosamide in vivo treatment of ALS-FUS mice reduces the expression of S100A4, &#x3b1;-SMA, and PDGFR&#x3b2; in the spinal cord, as well as gliosis in central and peripheral nervous tissues, together with axonal impairment and displays beneficial effects on muscle atrophy, by promoting muscle regeneration and reducing fibrosis.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our findings show that S100A4 has a role in ALS-related mechanisms, and that drugs such as niclosamide which are able to target inflammatory and fibrotic pathways could represent promising pharmacological tools for ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Milani</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Rome "Tor Vergata", Via della Ricerca Scientifica, 1, 00133, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mammarella</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Rome "Tor Vergata", Via della Ricerca Scientifica, 1, 00133, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Translational Pharmacology, CNR, 00133, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miele</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Rome "Tor Vergata", Via della Ricerca Scientifica, 1, 00133, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lattante</LastName><ForeName>Serena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unit&#xe0; Operativa Complessa di Genetica Medica, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sezione di Medicina Genomica, Universit&#xe0; Cattolica del Sacro Cuore, 00168, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabatelli</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unit&#xe0; Operativa Complessa di Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro Clinico NEMO, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sezione di Neurologia, Universit&#xe0; Cattolica del Sacro Cuore, 00168, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cozzolino</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Translational Pharmacology, CNR, 00133, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Ambrosi</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Rome "Tor Vergata", Via della Ricerca Scientifica, 1, 00133, Rome, Italy. nadia.dambrosi@uniroma2.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apolloni</LastName><ForeName>Savina</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5782-1665</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Rome "Tor Vergata", Via della Ricerca Scientifica, 1, 00133, Rome, Italy. savina.apolloni@uniroma2.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>SpliceALS</GrantID><Agency>Agenzia di Ricerca per la Sclerosi Laterale Amiotrofica</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neuroinflammation</MedlineTA><NlmUniqueID>101222974</NlmUniqueID><ISSNLinking>1742-2094</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071999">S100 Calcium-Binding Protein A4</NameOfSubstance></Chemical><Chemical><RegistryNumber>8KK8CQ2K8G</RegistryNumber><NameOfSubstance UI="D009534">Niclosamide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.1</RegistryNumber><NameOfSubstance UI="C546842">MTOR protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030801" MajorTopicYN="N">Animals, Genetically Modified</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009534" MajorTopicYN="N">Niclosamide</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071999" MajorTopicYN="N">S100 Calcium-Binding Protein A4</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">FUS</Keyword><Keyword MajorTopicYN="N">Fibroblasts</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">S100A4</Keyword><Keyword MajorTopicYN="N">&#x3b1;-SMA</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>13</Day><Hour>20</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34118929</ArticleId><ArticleId IdType="pmc">PMC8196441</ArticleId><ArticleId IdType="doi">10.1186/s12974-021-02184-1</ArticleId><ArticleId IdType="pii">10.1186/s12974-021-02184-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Apolloni S, Amadio S, Fabbrizio P, Morello G, Spampinato AG, Latagliata EC, Salvatori I, Proietti D, Ferri A, Madaro L, Puglisi-Allegra S, Cavallaro S, Volont&#xe9; C. Histaminergic transmission slows progression of amyotrophic lateral sclerosis. J Cachexia Sarcopenia Muscle. 2019;10(4):872&#x2013;893. doi: 10.1002/jcsm.12422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12422</ArticleId><ArticleId IdType="pmc">PMC6711424</ArticleId><ArticleId IdType="pubmed">31020811</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Appel SH. Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol. 2019;18(2):211&#x2013;220. doi: 10.1016/S1474-4422(18)30394-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30394-6</ArticleId><ArticleId IdType="pubmed">30663610</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berg LH, Sorenson E, Gronseth G, Macklin EA, Andrews J, Baloh RH, Benatar M, Berry JD, Chio A, Corcia P, Genge A, Gubitz AK, Lomen-Hoerth C, CJ MD, Pioro EP, Rosenfeld J, Silani V, Turner MR, Weber M, Brooks BR, Miller RG, Mitsumoto H, for the Airlie House ALS Clinical Trials Guidelines Group Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials. Neurology. 2019;92(14):e1610&#x2013;e1623. doi: 10.1212/WNL.0000000000007242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000007242</ArticleId><ArticleId IdType="pmc">PMC6448453</ArticleId><ArticleId IdType="pubmed">30850440</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyapally R, Pulivendala G, Bale S, Godugu C. Niclosamide alleviates pulmonary fibrosis in vitro and in vivo by attenuation of epithelial-to-mesenchymal transition, matrix proteins &amp; Wnt/&#x3b2;-catenin signaling: a drug repurposing study. Life Sci. 2019;220:8&#x2013;20. doi: 10.1016/j.lfs.2018.12.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2018.12.061</ArticleId><ArticleId IdType="pubmed">30611787</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradbury EJ, Burnside ER. Moving beyond the glial scar for spinal cord repair. Nat Commun. 2019;10(1):3879. doi: 10.1038/s41467-019-11707-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11707-7</ArticleId><ArticleId IdType="pmc">PMC6713740</ArticleId><ArticleId IdType="pubmed">31462640</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrita I, Benedetto R, Schreiber R, Kunzelmann K. Niclosamide repurposed for the treatment of inflammatory airway disease. JCI Insight. 2019;4(15):4. doi: 10.1172/jci.insight.128414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.128414</ArticleId><ArticleId IdType="pmc">PMC6693830</ArticleId><ArticleId IdType="pubmed">31391337</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty D, &#x160;umov&#xe1; B, Mallano T, Chen C-W, Distler A, Bergmann C, Ludolph I, Horch RE, Gelse K, Ramming A, Distler O, Schett G, &#x160;enolt L, Distler JHW. Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis. Nat Commun. 2017;8(1):1130. doi: 10.1038/s41467-017-01236-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01236-6</ArticleId><ArticleId IdType="pmc">PMC5654983</ArticleId><ArticleId IdType="pubmed">29066712</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Mook RA, Premont RT, Wang J. Niclosamide: beyond an antihelminthic drug. Cell Signal. 2018;41:89&#x2013;96. doi: 10.1016/j.cellsig.2017.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2017.04.001</ArticleId><ArticleId IdType="pmc">PMC5628105</ArticleId><ArticleId IdType="pubmed">28389414</ArticleId></ArticleIdList></Reference><Reference><Citation>Cykowski MD, Powell SZ, Appel JW, Arumanayagam AS, Rivera AL, Appel SH. Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2018;6(1):28. doi: 10.1186/s40478-018-0528-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0528-y</ArticleId><ArticleId IdType="pmc">PMC5899326</ArticleId><ArticleId IdType="pubmed">29653597</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ambrosi N, Apolloni S. Fibrotic scar in neurodegenerative diseases. Front Immunol. 2020;11:1394. doi: 10.3389/fimmu.2020.01394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01394</ArticleId><ArticleId IdType="pmc">PMC7456854</ArticleId><ArticleId IdType="pubmed">32922384</ArticleId></ArticleIdList></Reference><Reference><Citation>Dmytriyeva O, Pankratova S, Owczarek S, Sonn K, Soroka V, Ridley CM, Marsolais A, Lopez-Hoyos M, Ambartsumian N, Lukanidin E, Bock E, Berezin V, Kiryushko D. The metastasis-promoting S100A4 protein confers neuroprotection in brain injury. Nat Commun. 2012;3(1):1197. doi: 10.1038/ncomms2202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2202</ArticleId><ArticleId IdType="pubmed">23149742</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorrier CE, Aran D, Haenelt EA, Sheehy RN, Hoi KK, Pintari&#x107; L, Chen Y, Lizama CO, Cautivo KM, Weiner GA, Popko B, Fancy SPJ, Arnold TD, Daneman R. CNS fibroblasts form a fibrotic scar in response to immune cell infiltration. Nat Neurosci. 2021;24(2):234&#x2013;244. doi: 10.1038/s41593-020-00770-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00770-9</ArticleId><ArticleId IdType="pmc">PMC7877789</ArticleId><ArticleId IdType="pubmed">33526922</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbrizio P, Apolloni S, Bianchi A, Salvatori I, Valle C, Lanzuolo C, Bendotti C, Nardo G, Volont&#xe9; C. P2X7 activation enhances skeletal muscle metabolism and regeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis. Brain Pathol. 2020;30(2):272&#x2013;282. doi: 10.1111/bpa.12774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12774</ArticleId><ArticleId IdType="pmc">PMC7065186</ArticleId><ArticleId IdType="pubmed">31376190</ArticleId></ArticleIdList></Reference><Reference><Citation>Fei F, Qu J, Li C, Wang X, Li Y, Zhang S. Role of metastasis-induced protein S100A4 in human non-tumor pathophysiologies. Cell Biosci. 2017;7(1):64. doi: 10.1186/s13578-017-0191-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-017-0191-1</ArticleId><ArticleId IdType="pmc">PMC5702147</ArticleId><ArticleId IdType="pubmed">29204268</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Klett F, Priller J. The fibrotic scar in neurological disorders. Brain Pathol. 2014;24(4):404&#x2013;413. doi: 10.1111/bpa.12162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12162</ArticleId><ArticleId IdType="pmc">PMC8029481</ArticleId><ArticleId IdType="pubmed">24946078</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez D, Contreras O, Rebolledo DL, Espinoza JP, van Zundert B, Brandan E. ALS skeletal muscle shows enhanced TGF-&#x3b2; signaling, fibrosis and induction of fibro/adipogenic progenitor markers. Plos One. 2017;12(5):e0177649. doi: 10.1371/journal.pone.0177649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0177649</ArticleId><ArticleId IdType="pmc">PMC5433732</ArticleId><ArticleId IdType="pubmed">28520806</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamdoun S, Jung P, Efferth T. Drug repurposing of the anthelmintic niclosamide to treat multidrug-resistant leukemia. Front Pharmacol. 2017;8:110. doi: 10.3389/fphar.2017.00110.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2017.00110</ArticleId><ArticleId IdType="pmc">PMC5344920</ArticleId><ArticleId IdType="pubmed">28344555</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou J, Ma T, Cao H, Chen Y, Wang C, Chen X, Xiang Z, Han X. TNF-&#x3b1;-induced NF-&#x3ba;B activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis. J Cell Physiol. 2018;233(3):2409&#x2013;2419. doi: 10.1002/jcp.26112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.26112</ArticleId><ArticleId IdType="pubmed">28731277</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou S, Tian T, Qi D, Sun K, Yuan Q, Wang Z, Qin Z, Wu Z, Chen Z, Zhang J. S100A4 promotes lung tumor development through &#x3b2;-catenin pathway-mediated autophagy inhibition. Cell Death Dis. 2018;9(3):277. doi: 10.1038/s41419-018-0319-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0319-1</ArticleId><ArticleId IdType="pmc">PMC5833421</ArticleId><ArticleId IdType="pubmed">29449540</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadri H, Lambourne OA, Mehellou Y. Niclosamide, a drug with many (re)purposes. ChemMedChem. 2018;13(11):1088&#x2013;1091. doi: 10.1002/cmdc.201800100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cmdc.201800100</ArticleId><ArticleId IdType="pmc">PMC7162286</ArticleId><ArticleId IdType="pubmed">29603892</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasembeli MM, Bharadwaj U, Robinson P, Tweardy DJ. Contribution of STAT3 to inflammatory and fibrotic diseases and prospects for its targeting for treatment. Int J Mol Sci. 2018;19(8). 10.3390/ijms19082299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6121470</ArticleId><ArticleId IdType="pubmed">30081609</ArticleId></ArticleIdList></Reference><Reference><Citation>Konrad C, Kawamata H, Bredvik KG, Arreguin AJ, Cajamarca SA, Hupf JC, Ravits JM, Miller TM, Maragakis NJ, Hales CM, Glass JD, Gross S, Mitsumoto H, Manfredi G. Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients. Mol Neurodegener. 2017;12(1):76. doi: 10.1186/s13024-017-0217-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0217-5</ArticleId><ArticleId IdType="pmc">PMC5655870</ArticleId><ArticleId IdType="pubmed">29065921</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S, Marangi G, Doronzio PN, Conte A, Bisogni G, Zollino M, et al. High-throughput genetic testing in ALS: the challenging path of variant classification considering the ACMG guidelines. Genes (Basel). 2020;11(10). 10.3390/genes11101123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7600768</ArticleId><ArticleId IdType="pubmed">32987860</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemke A, Penzenstadler C, Ferguson J, Lidinsky D, Hopf R, Bradl M, Redl H, Wolbank S, Hausner T. A novel experimental rat model of peripheral nerve scarring that reliably mimics post-surgical complications and recurring adhesions. Dis Model Mech. 2017;10:1015&#x2013;1025. doi: 10.1242/dmm.028852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.028852</ArticleId><ArticleId IdType="pmc">PMC5560061</ArticleId><ArticleId IdType="pubmed">28550101</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Li Y, Liu S, Qin Z. Extracellular S100A4 as a key player in fibrotic diseases. J Cell Mol Med. 2020;24(11):5973&#x2013;5983. doi: 10.1111/jcmm.15259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.15259</ArticleId><ArticleId IdType="pmc">PMC7294136</ArticleId><ArticleId IdType="pubmed">32307910</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang L, Huang M, Xiao Y, Zen S, Lao M, Zou Y, Shi M, Yang X, Xu H. Inhibitory effects of niclosamide on inflammation and migration of fibroblast-like synoviocytes from patients with rheumatoid arthritis. Inflamm Res. 2015;64(3-4):225&#x2013;233. doi: 10.1007/s00011-015-0801-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-015-0801-5</ArticleId><ArticleId IdType="pubmed">25708600</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S-C, Dastidar SG, Tokunaga S, Ho WY, Lim K, Ilieva H, et al. Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy-lysosome axis. Elife. 2019;8. 10.7554/eLife.40811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6389288</ArticleId><ArticleId IdType="pubmed">30747709</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Zou X-Z, Huang N, Ge X-Y, Yao M-Z, Liu H, Zhang Z, Hu C-P. Down-regulation of miR-204 attenuates endothelial-mesenchymal transition by enhancing autophagy in hypoxia-induced pulmonary hypertension. Eur J Pharmacol. 2019;863:172673. doi: 10.1016/j.ejphar.2019.172673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2019.172673</ArticleId><ArticleId IdType="pubmed">31542480</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Luo X, Shan H, Fu Y, Gu Q, Zheng X, et al. Niclosamide triggers non-canonical LC3 lipidation. Cells. 2019;8(3). 10.3390/cells8030248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6468753</ArticleId><ArticleId IdType="pubmed">30875964</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J-H, Qi J, Lin S-Q, Zhang C-Y, Liu F-Y, Xie W-D, Li X. STAT3 Targets ERR-&#x3b1; to promote epithelial-mesenchymal transition, migration, and invasion in triple-negative breast cancer cells. Mol Cancer Res. 2019;17(11):2184&#x2013;2195. doi: 10.1158/1541-7786.MCR-18-1194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1541-7786.MCR-18-1194</ArticleId><ArticleId IdType="pubmed">31427441</ArticleId></ArticleIdList></Reference><Reference><Citation>Madaro L, Passafaro M, Sala D, Etxaniz U, Lugarini F, Proietti D, Alfonsi MV, Nicoletti C, Gatto S, De Bardi M, Rojas-Garc&#xed;a R, Giordani L, Marinelli S, Pagliarini V, Sette C, Sacco A, Puri PL. Denervation-activated STAT3-IL-6 signalling in fibro-adipogenic progenitors promotes myofibres atrophy and fibrosis. Nat Cell Biol. 2018;20(8):917&#x2013;927. doi: 10.1038/s41556-018-0151-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-018-0151-y</ArticleId><ArticleId IdType="pmc">PMC6145844</ArticleId><ArticleId IdType="pubmed">30050118</ArticleId></ArticleIdList></Reference><Reference><Citation>Maguire G. Neurodegenerative diseases are a function of matrix breakdown: how to rebuild extracellular matrix and intracellular matrix. Neural Regen Res. 2018;13(7):1185&#x2013;1186. doi: 10.4103/1673-5374.235026.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.235026</ArticleId><ArticleId IdType="pmc">PMC6065239</ArticleId><ArticleId IdType="pubmed">30028322</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirra A, Rossi S, Scaricamazza S, Di Salvio M, Salvatori I, Valle C, Rusmini P, Poletti A, Cestra G, Carr&#xec; MT, Cozzolino M. Functional interaction between FUS and SMN underlies SMA-like splicing changes in wild-type hFUS mice. Sci Rep. 2017;7(1):2033. doi: 10.1038/s41598-017-02195-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-02195-0</ArticleId><ArticleId IdType="pmc">PMC5435706</ArticleId><ArticleId IdType="pubmed">28515487</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollinari C, Zhao J, Lupacchini L, Garaci E, Merlo D, Pei G. Transdifferentiation: a new promise for neurodegenerative diseases. Cell Death Dis. 2018;9(8):830. doi: 10.1038/s41419-018-0891-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0891-4</ArticleId><ArticleId IdType="pmc">PMC6078988</ArticleId><ArticleId IdType="pubmed">30082779</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan R, Singal V, Benes R, Gao J, Chan H, Chen H, Yu Y, Zhou J, Wu P. STAT3 modulation to enhance motor neuron differentiation in human neural stem cells. Plos One. 2014;9(6):e100405. doi: 10.1371/journal.pone.0100405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0100405</ArticleId><ArticleId IdType="pmc">PMC4063761</ArticleId><ArticleId IdType="pubmed">24945434</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HP, Van Broeckhoven C, van der Zee J. ALS Genes in the genomic era and their Implications for FTD. Trends Genet. 2018;34(6):404&#x2013;423. doi: 10.1016/j.tig.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Noori A, Mezlini AM, Hyman BT, Serrano-Pozo A, Das S. Differential gene expression data from the human central nervous system across Alzheimer&#x2019;s disease, Lewy body diseases, and the amyotrophic lateral sclerosis and frontotemporal dementia spectrum. Data Brief. 2021;35:106863. doi: 10.1016/j.dib.2021.106863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dib.2021.106863</ArticleId><ArticleId IdType="pmc">PMC7903289</ArticleId><ArticleId IdType="pubmed">33665258</ArticleId></ArticleIdList></Reference><Reference><Citation>Noori A, Mezlini AM, Hyman BT, Serrano-Pozo A, Das S. Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across neurodegeneration. Neurobiol Dis. 2021;149:105225. doi: 10.1016/j.nbd.2020.105225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105225</ArticleId><ArticleId IdType="pmc">PMC7856076</ArticleId><ArticleId IdType="pubmed">33347974</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesto E, Colombrita C, Gumina V, Borghi MO, Dusi S, Doretti A, Fagiolari G, Invernizzi F, Moggio M, Tiranti V, Silani V, Ratti A. Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts. Acta Neuropathol Commun. 2016;4(1):47. doi: 10.1186/s40478-016-0316-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0316-5</ArticleId><ArticleId IdType="pmc">PMC4858818</ArticleId><ArticleId IdType="pubmed">27151080</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zt&#xfc;rk Akcora B, Vassilios Gabri&#xeb;l A, Ortiz-Perez A, Bansal R. Pharmacological inhibition of STAT3 pathway ameliorates acute liver injury in vivo via inactivation of inflammatory macrophages and hepatic stellate cells. FASEB Bioadv. 2020;2(2):77&#x2013;89. doi: 10.1096/fba.2019-00070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fba.2019-00070</ArticleId><ArticleId IdType="pmc">PMC7003653</ArticleId><ArticleId IdType="pubmed">32123858</ArticleId></ArticleIdList></Reference><Reference><Citation>Par&#xe9; B, Gros-Louis F. Potential skin involvement in ALS: revisiting Charcot&#x2019;s observation&#x2014;a review of skin abnormalities in ALS. Rev Neurosci. 2017;28(5):551&#x2013;572. doi: 10.1515/revneuro-2017-0004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2017-0004</ArticleId><ArticleId IdType="pubmed">28343168</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters S, Zitzelsperger E, Kuespert S, Iberl S, Heydn R, Johannesen S, Petri S, Aigner L, Thal DR, Hermann A, Weishaupt JH, Bruun T-H, Bogdahn U. The TGF-&#x3b2; system as a potential pathogenic player in disease modulation of amyotrophic lateral sclerosis. Front Neurol. 2017;8:669. doi: 10.3389/fneur.2017.00669.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00669</ArticleId><ArticleId IdType="pmc">PMC5736544</ArticleId><ArticleId IdType="pubmed">29326641</ArticleId></ArticleIdList></Reference><Reference><Citation>Piera-Velazquez S, Jimenez SA. Endothelial to mesenchymal transition: role in Physiology and in the pathogenesis of human diseases. Physiol Rev. 2019;99(2):1281&#x2013;1324. doi: 10.1152/physrev.00021.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00021.2018</ArticleId><ArticleId IdType="pmc">PMC6734087</ArticleId><ArticleId IdType="pubmed">30864875</ArticleId></ArticleIdList></Reference><Reference><Citation>Pikor NB, Cupovic J, Onder L, Gommerman JL, Ludewig B. Stromal cell niches in the inflamed central nervous system. J Immunol. 2017;198(5):1775&#x2013;1781. doi: 10.4049/jimmunol.1601566.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1601566</ArticleId><ArticleId IdType="pubmed">28223405</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xf6;l&#xf6;nen P, Jawahar Deen A, Leinonen HM, Jyrkk&#xe4;nen H-K, Kuosmanen S, Mononen M, Jain A, Tuomainen T, Pasonen-Sepp&#xe4;nen S, Hartikainen JM, Mannermaa A, Nykter M, Tavi P, Johansen T, Hein&#xe4;niemi M, Levonen A-L. Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma. Oncogene. 2019;38(50):7473&#x2013;7490. doi: 10.1038/s41388-019-0956-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41388-019-0956-6</ArticleId><ArticleId IdType="pubmed">31444413</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu H, Lee S, Shang Y, Wang W-Y, Au KF, Kamiya S, Barmada SJ, Finkbeiner S, Lui H, Carlton CE, Tang AA, Oldham MC, Wang H, Shorter J, Filiano AJ, Roberson ED, Tourtellotte WG, Chen B, Tsai L-H, Huang EJ. ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J Clin Invest. 2014;124(3):981&#x2013;999. doi: 10.1172/JCI72723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI72723</ArticleId><ArticleId IdType="pmc">PMC3938263</ArticleId><ArticleId IdType="pubmed">24509083</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A, Gumina V, Lenzi P, Bossolasco P, Fulceri F, Volpe C, Bardelli D, Pregnolato F, Maraschi A, Fornai F, Silani V, Colombrita C. Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons. Neurobiol Dis. 2020;145:105051. doi: 10.1016/j.nbd.2020.105051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105051</ArticleId><ArticleId IdType="pubmed">32827688</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren X, Duan L, He Q, Zhang Z, Zhou Y, Wu D, Pan J, Pei D, Ding K. Identification of niclosamide as a new small-molecule inhibitor of the STAT3 signaling pathway. ACS Med Chem Lett. 2010;1(9):454&#x2013;459. doi: 10.1021/ml100146z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ml100146z</ArticleId><ArticleId IdType="pmc">PMC4007964</ArticleId><ArticleId IdType="pubmed">24900231</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Sim&#xf3;n-S&#xe1;nchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita V-M, Kaivorinne A-L, H&#xf6;ltt&#xe4;-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chi&#xf2; A, Restagno G, Borghero G, Sabatelli M, ITALSGEN Consortium. Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Riancho J, Arozamena S, L&#xf3;pez de Muna&#xed;n A. Dermic-derived fibroblasts for the study of amyotrophic lateral sclerosis. Neural Regen Res. 2020;15(11):2043&#x2013;2044. doi: 10.4103/1673-5374.282257.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.282257</ArticleId><ArticleId IdType="pmc">PMC7716046</ArticleId><ArticleId IdType="pubmed">32394958</ArticleId></ArticleIdList></Reference><Reference><Citation>Riancho J, Castanedo-V&#xe1;zquez D, Gil-Bea F, Tapia O, Arozamena J, Dur&#xe1;n-V&#xed;an C, Sedano MJ, Berciano MT, Lopez de Munain A, Lafarga M. ALS-derived fibroblasts exhibit reduced proliferation rate, cytoplasmic TDP-43 aggregation and a higher susceptibility to DNA damage. J Neurol. 2020;267(5):1291&#x2013;1299. doi: 10.1007/s00415-020-09704-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09704-8</ArticleId><ArticleId IdType="pubmed">31938860</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossaert E, Pollari E, Jaspers T, Van Helleputte L, Jarpe M, Van Damme P, De Bock K, Moisse M, Van Den Bosch L. Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model. Acta Neuropathol Commun. 2019;7(1):107. doi: 10.1186/s40478-019-0750-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0750-2</ArticleId><ArticleId IdType="pmc">PMC6612190</ArticleId><ArticleId IdType="pubmed">31277703</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruma IMW, Kinoshita R, Tomonobu N, Inoue Y, Kondo E, Yamauchi A, et al. Embigin promotes prostate cancer progression by S100A4-dependent and-independent mechanisms. Cancers (Basel). 2018;10(7). 10.3390/cancers10070239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6071117</ArticleId><ArticleId IdType="pubmed">30041429</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M, Zollino M, Conte A, Del Grande A, Marangi G, Lucchini M, Mirabella M, Romano A, Piacentini R, Bisogni G, Lattante S, Luigetti M, Rossini PM, Moncada A. Primary fibroblasts cultures reveal TDP-43 abnormalities in amyotrophic lateral sclerosis patients with and without SOD1 mutations. Neurobiol Aging. 2015;36:2005.e5&#x2013;2005.e13. doi: 10.1016/j.neurobiolaging.2015.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.02.009</ArticleId><ArticleId IdType="pubmed">25792239</ArticleId></ArticleIdList></Reference><Reference><Citation>Sack U, Walther W, Scudiero D, Selby M, Kobelt D, Lemm M, Fichtner I, Schlag PM, Shoemaker RH, Stein U. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer. J Natl Cancer Inst. 2011;103(13):1018&#x2013;1036. doi: 10.1093/jnci/djr190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djr190</ArticleId><ArticleId IdType="pubmed">21685359</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaricamazza S, Salvatori I, Giacovazzo G, Loeffler JP, Ren&#xe8; F, Rosina M, Quessada C, Proietti D, Heil C, Rossi S, Battistini S, Giannini F, Volpi N, Steyn FJ, Ngo ST, Ferraro E, Madaro L, Coccurello R, Valle C, Ferri A. Skeletal-muscle metabolic reprogramming in ALS-SOD1G93A mice predates disease onset and is a promising therapeutic target. iScience. 2020;23(5):101087. doi: 10.1016/j.isci.2020.101087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101087</ArticleId><ArticleId IdType="pmc">PMC7200935</ArticleId><ArticleId IdType="pubmed">32371370</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekulovski N, Whorton AE, Tanaka T, Hirota Y, Shi M, MacLean JA, de Mola JRL, Groesch K, Diaz-Sylvester P, Wilson T, Hayashi K. Niclosamide suppresses macrophage-induced inflammation in endometriosis&#x2020;. Biol Reprod. 2020;102(5):1011&#x2013;1019. doi: 10.1093/biolre/ioaa010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biolre/ioaa010</ArticleId><ArticleId IdType="pmc">PMC7186788</ArticleId><ArticleId IdType="pubmed">31950153</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano A, Apolloni S, Rossi S, Lattante S, Sabatelli M, Peric M, et al. The S100A4 transcriptional inhibitor niclosamide reduces pro-inflammatory and migratory phenotypes of microglia: implications for amyotrophic lateral sclerosis. Cells. 2019;8(10). 10.3390/cells8101261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6829868</ArticleId><ArticleId IdType="pubmed">31623154</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Lin S, Staats KA, Li Y, Chang W-H, Hung S-T, Hendricks E, Linares GR, Wang Y, Son EY, Wen X, Kisler K, Wilkinson B, Menendez L, Sugawara T, Woolwine P, Huang M, Cowan MJ, Ge B, Koutsodendris N, Sandor KP, Komberg J, Vangoor VR, Senthilkumar K, Hennes V, Seah C, Nelson AR, Cheng T-Y, Lee S-JJ, August PR, Chen JA, Wisniewski N, Hanson-Smith V, Belgard TG, Zhang A, Coba M, Grunseich C, Ward ME, van den Berg LH, Pasterkamp RJ, Trotti D, Zlokovic BV, Ichida JK. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat Med. 2018;24(3):313&#x2013;325. doi: 10.1038/nm.4490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart RL, Carpenter BL, West DS, Knifley T, Liu L, Wang C, Weiss HL, Gal TS, Durbin EB, Arnold SM, O&#x2019;Connor KL, Chen M. S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide. Oncotarget. 2016;7:34630&#x2013;34642. doi: 10.18632/oncotarget.8969.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.8969</ArticleId><ArticleId IdType="pmc">PMC5085181</ArticleId><ArticleId IdType="pubmed">27127879</ArticleId></ArticleIdList></Reference><Reference><Citation>Suk TR, Rousseaux MWC. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegeneration. 2020;15(1):45. doi: 10.1186/s13024-020-00397-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00397-1</ArticleId><ArticleId IdType="pmc">PMC7429473</ArticleId><ArticleId IdType="pubmed">32799899</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;umov&#xe1; B, Cerezo LA, Szczukov&#xe1; L, Nekvindov&#xe1; L, Uher M, Hulejov&#xe1; H, Moravcov&#xe1; R, Grigorian M, Pavelka K, Vencovsk&#xfd; J, &#x160;enolt L, Z&#xe1;vada J. Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study. Rheumatol Int. 2019;39(3):469&#x2013;478. doi: 10.1007/s00296-018-4190-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-018-4190-2</ArticleId><ArticleId IdType="pubmed">30392117</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, Sun Y, Ling S-C, Ferraiuolo L, McAlonis-Downes M, Zou Y, Drenner K, Wang Y, Ditsworth D, Tokunaga S, Kopelevich A, Kaspar BK, Lagier-Tourenne C, Cleveland DW. Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS. Proc Natl Acad Sci U S A. 2015;112(50):E6993&#x2013;E7002. doi: 10.1073/pnas.1520639112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1520639112</ArticleId><ArticleId IdType="pmc">PMC4687558</ArticleId><ArticleId IdType="pubmed">26621731</ArticleId></ArticleIdList></Reference><Reference><Citation>Tank EM, Figueroa-Romero C, Hinder LM, Bedi K, Archbold HC, Li X, Weskamp K, Safren N, Paez-Colasante X, Pacut C, Thumma S, Paulsen MT, Guo K, Hur J, Ljungman M, Feldman EL, Barmada SJ. Abnormal RNA stability in amyotrophic lateral sclerosis. Nat Commun. 2018;9(1):2845. doi: 10.1038/s41467-018-05049-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05049-z</ArticleId><ArticleId IdType="pmc">PMC6054632</ArticleId><ArticleId IdType="pubmed">30030424</ArticleId></ArticleIdList></Reference><Reference><Citation>Testa S, D&#x2019;Addabbo P, Fornetti E, Belli R, Fuoco C, Bernardini S, Cannata S, Frezza D, Gargioli C. Myoblast myogenic differentiation but not fusion process is inhibited via MyoD Tetraplex interaction. Oxid Med Cell Longev. 2018;2018:7640272&#x2013;7640278. doi: 10.1155/2018/7640272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/7640272</ArticleId><ArticleId IdType="pmc">PMC5964432</ArticleId><ArticleId IdType="pubmed">29854094</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomcik M, Palumbo-Zerr K, Zerr P, Avouac J, Dees C, Sumova B, Distler A, Beyer C, Cerezo LA, Becvar R, Distler O, Grigorian M, Schett G, Senolt L, Distler JHW. S100A4 amplifies TGF-&#x3b2;-induced fibroblast activation in systemic sclerosis. Ann Rheum Dis. 2015;74(9):1748&#x2013;1755. doi: 10.1136/annrheumdis-2013-204516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-204516</ArticleId><ArticleId IdType="pubmed">24709861</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieland A, Trageser D, Gogolok S, Reinartz R, H&#xf6;fer H, Keller M, Leinhaas A, Schelle R, Normann S, Klaas L, Waha A, Koch P, Fimmers R, Pietsch T, Yachnis AT, Pincus DW, Steindler DA, Br&#xfc;stle O, Simon M, Glas M, Scheffler B. Anticancer effects of niclosamide in human glioblastoma. Clin Cancer Res. 2013;19(15):4124&#x2013;4136. doi: 10.1158/1078-0432.CCR-12-2895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-12-2895</ArticleId><ArticleId IdType="pubmed">23908450</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B, Ivanov P. Stress granules and neurodegeneration. Nat Rev Neurosci. 2019;20(11):649&#x2013;666. doi: 10.1038/s41583-019-0222-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-019-0222-5</ArticleId><ArticleId IdType="pmc">PMC6986315</ArticleId><ArticleId IdType="pubmed">31582840</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C-S, Li Y-R, Chen JJW, Chen Y-C, Chu C-L, Pan I-H, Wu Y-S, Lin C-C. Antihelminthic niclosamide modulates dendritic cells activation and function. Cell Immunol. 2014;288(1-2):15&#x2013;23. doi: 10.1016/j.cellimm.2013.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2013.12.006</ArticleId><ArticleId IdType="pmc">PMC7094312</ArticleId><ArticleId IdType="pubmed">24561310</ArticleId></ArticleIdList></Reference><Reference><Citation>Yahn SL, Li J, Goo I, Gao H, Brambilla R, Lee JK. Fibrotic scar after experimental autoimmune encephalomyelitis inhibits oligodendrocyte differentiation. Neurobiol Dis. 2020;134:104674. doi: 10.1016/j.nbd.2019.104674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104674</ArticleId><ArticleId IdType="pmc">PMC7547849</ArticleId><ArticleId IdType="pubmed">31731043</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye T, Xiong Y, Yan Y, Xia Y, Song X, Liu L, Li D, Wang N, Zhang L, Zhu Y, Zeng J, Wei Y, Yu L. The anthelmintic drug niclosamide induces apoptosis, impairs metastasis and reduces immunosuppressive cells in breast cancer model. Plos One. 2014;9(1):e85887. doi: 10.1371/journal.pone.0085887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0085887</ArticleId><ArticleId IdType="pmc">PMC3885752</ArticleId><ArticleId IdType="pubmed">24416452</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Tang L, Huang T, Fan D. Life course adiposity and amyotrophic lateral sclerosis: a mendelian randomization study. Ann Neurol. 2020;87(3):434&#x2013;441. doi: 10.1002/ana.25671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25671</ArticleId><ArticleId IdType="pubmed">31916305</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou T, Zheng Y, Sun L, Badea SR, Jin Y, Liu Y, Rolfe AJ, Sun H, Wang X, Cheng Z, Huang Z, Zhao N, Sun X, Li J, Fan J, Lee C, Megraw TL, Wu W, Wang G, Ren Y. Microvascular endothelial cells engulf myelin debris and promote macrophage recruitment and fibrosis after neural injury. Nat Neurosci. 2019;22(3):421&#x2013;435. doi: 10.1038/s41593-018-0324-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0324-9</ArticleId><ArticleId IdType="pmc">PMC6913093</ArticleId><ArticleId IdType="pubmed">30664769</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>